Champions Oncology (CSBR) Profit After Tax (2010 - 2026)

Champions Oncology (CSBR) has 17 years of Profit After Tax data on file, last reported at -$426000.0 in Q3 2026.

• On a quarterly basis, Profit After Tax rose 8.58% year-over-year to -$426000.0 in Q3 2026; TTM through Jul 2026 was -$1.1 million, a 138.64% decrease from a year earlier, with the FY2026 full-year figure at -$1.2 million, down 125.53% from the prior year.
• Profit After Tax for Q3 2026 stood at -$426000.0, up from -$692000.0 in the prior quarter.
• Across five years, Profit After Tax topped out at $4.5 million in Q1 2025 and bottomed at -$2.6 million in Q3 2023.
• Historically, Profit After Tax has averaged -$476947.4 across 5 years, with a median of -$344000.0 in 2022.
• The widest annual swing landed in 2023, when Profit After Tax plunged 12843.75%; it then surged 277.67% in 2025.
• Year by year, Profit After Tax stood at -$16000.0 in 2022, then plunged by 12843.75% to -$2.1 million in 2023, then soared by 135.15% to $728000.0 in 2024, then tumbled by 63.19% to $268000.0 in 2025, then tumbled by 258.96% to -$426000.0 in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$426000.0 in Q3 2026, -$692000.0 in Q2 2026, and -$279000.0 in Q1 2026.